UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update on group A streptococcal vaccine development

Current opinion in infectious diseases, 2020-06, Vol.33 (3), p.244-250

2020

Volltextzugriff (PDF)

Potential coverage of a multivalent M protein-based group A streptococcal vaccine

Vaccine, 2013-03, Vol.31 (12), p.1576-1581

2013

Volltextzugriff (PDF)

Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection

PloS one, 2020-06, Vol.15 (6), p.e0235139

2020

Volltextzugriff (PDF)

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

PloS one, 2009-01, Vol.4 (1), p.e4166-e4166

2009

Volltextzugriff (PDF)

Prevalence of Rheumatic Heart Disease in Children and Young Adults in Nicaragua

The American journal of cardiology, 2010-06, Vol.105 (12), p.1809-1814

2010

Volltextzugriff (PDF)

Seven-Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates

Clinical infectious diseases, 2009-07, Vol.49 (1), p.78-84

2009

Volltextzugriff (PDF)

Current status of group A streptococcal vaccine development

Advances in experimental medicine and biology, 2008, Vol.609, p.53

Dale, James B

2008

Volltextzugriff (PDF)

Prevalence of group A β-hemolytic streptococcal throat carriage and prospective pilot surveillance of streptococcal sore throat in Ugandan school children

International journal of infectious diseases, 2020-04, Vol.93, p.245-251

2020

Volltextzugriff (PDF)

The Importance of the Group A Streptococcus Capsule in the Pathogenesis of Human Infections: A Historical Perspective

Clinical infectious diseases, 2008-04, Vol.46 (7), p.1038-1045

2008

Volltextzugriff (PDF)

One More Disguise in the Stealth Behavior of Streptococcus pyogenes

mBio, 2016-05, Vol.7 (3)

2016

Volltextzugriff (PDF)

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Clinical infectious diseases, 2005-10, Vol.41 (8), p.1114-1122

2005

Volltextzugriff (PDF)

Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection

Cell, 2018-05, Vol.173 (5), p.1083-1097.e22

2018

Volltextzugriff (PDF)

Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report

BMJ global health, 2023-10, Vol.8 (Suppl 9), p.e012356

2023

Volltextzugriff (PDF)

Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development

mSphere, 2020-07, Vol.5 (4)

2020

Volltextzugriff (PDF)

Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa

mSphere, 2023-06, Vol.8 (3), p.e0011323-e0011323

2023

Volltextzugriff (PDF)

Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti‐streptococcal vaccine

Microbiology and immunology, 2018-11, Vol.62 (11), p.711-719

2018

Volltextzugriff (PDF)

Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M‐protein antigens derived from Group A Streptococcus

Microbiology and immunology, 2018-06, Vol.62 (6), p.395-404

2018

Volltextzugriff (PDF)

Temporal Changes in Streptococcal M Protein Types and the Near-Disappearance of Acute Rheumatic Fever in the United States

Clinical infectious diseases, 2006-02, Vol.42 (4), p.441-447

2006

Volltextzugriff (PDF)

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

Vaccine, 2011-10, Vol.29 (46), p.8175-8178

2011

Volltextzugriff (PDF)

Immunogenicity of a 26-Valent Group A Streptococcal Vaccine

Infection and Immunity, 2002-04, Vol.70 (4), p.2171-2177

2002

Volltextzugriff (PDF)

Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic Review

Frontiers in cardiovascular medicine, 2021-07, Vol.8, p.691646-691646

2021

Volltextzugriff (PDF)

Prospects for a Group A Streptococcal Vaccine: Rationale, Feasibility, and Obstacles—Report of a National Institute of Allergy and Infectious Diseases Workshop

Clinical infectious diseases, 2005-10, Vol.41 (8), p.1150-1156

2005

Volltextzugriff (PDF)

Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine

Vaccine, 2023-09, Vol.41 (40), p.5841-5847

2023

Volltextzugriff (PDF)

Status of research and development of vaccines for Streptococcus pyogenes

Vaccine, 2016-06, Vol.34 (26), p.2953-2958

2016

Volltextzugriff (PDF)

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine

Vaccine, 2024-09, Vol.42 (22), p.126205, Article 126205

2024

Volltextzugriff (PDF)

1 – 25 von 1.405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.256)
Mit Volltextzugriff
(1.181)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(961)
Life Sciences & Biomedicine
(778)
Humans
(565)
Female
(315)
Biological And Medical Sciences
(288)
Male
(271)
Animals
(219)
Medical Sciences
(193)
Middle Aged
(161)
Adult
(140)
Physical Sciences
(128)
Aged
(116)
Immunology
(115)
Fundamental And Applied Biological Sciences. Psychology
(107)
Infectious Diseases
(93)
Microbiology
(92)
Risk Factors
(75)
Mice
(70)
Technology
(65)
Neurosciences & Neurology
(62)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Medicinal Chemistry
(25)
Plos One
(22)
Alzheimer's & Dementia
(21)
Vaccine
(19)
Journal Of Clinical Oncology
(18)
Journal Of Natural Products
(18)
Pediatrics
(18)
Clinical Infectious Diseases
(17)
Bioorganic & Medicinal Chemistry Letters
(15)
Nature
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Update on group A streptococcal vaccine development

Potential coverage of a multivalent M protein-based group A streptococcal vaccine

Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

Prevalence of Rheumatic Heart Disease in Children and Young Adults in Nicaragua

Seven-Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates

Current status of group A streptococcal vaccine development

Prevalence of group A β-hemolytic streptococcal throat carriage and prospective pilot surveillance of streptococcal sore throat in Ugandan school children

The Importance of the Group A Streptococcus Capsule in the Pathogenesis of Human Infections: A Historical Perspective

One More Disguise in the Stealth Behavior of Streptococcus pyogenes

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection

Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report

Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development

Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa

Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti‐streptococcal vaccine

Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M‐protein antigens derived from Group A Streptococcus

Temporal Changes in Streptococcal M Protein Types and the Near-Disappearance of Acute Rheumatic Fever in the United States

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

Immunogenicity of a 26-Valent Group A Streptococcal Vaccine

Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic Review

Prospects for a Group A Streptococcal Vaccine: Rationale, Feasibility, and Obstacles—Report of a National Institute of Allergy and Infectious Diseases Workshop

Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine

Status of research and development of vaccines for Streptococcus pyogenes

Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine

Suchergebnisse filtern